Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,051–8,075 of 27,380 studies, newest first · page 323 of 1096.

January 2023 25

  1. 2023-01-06

    Validity and reliability of a computerized cognitive function evaluation battery (CogEvo) as a screening tool

    ✓ Peer-reviewed Cognitive tests and assessment PCN reports : psychiatry and clinical neurosciences

    Key finding: Exploratory factor analysis revealed the orientation/spatial cognitive function (orientation and spatial cognition) and attention/executive function (attention, memory, and execution) factors. +4 more findings

  2. 2023-01-06

    Risk factors for falls among community-dwelling older adults: A systematic review and meta-analysis

    ✓ Peer-reviewed Clinical safety Frontiers in medicine

    Key finding: This study provides preliminary evidence that falls among community-dwelling older adults are associated with factors such as age, female gender, fear of falling, history of falls, unclear vision, depression, and balance disorders. +3 more findings

  3. 2023-01-06

    Mediterranean Diet, Ketogenic Diet or MIND Diet for Aging Populations with Cognitive Decline: A Systematic Review

    ✓ Peer-reviewed Prevention trials Life (Basel, Switzerland)

    Key finding: Only RCTs were included in this study; there were eleven studies ( n = 2609 participants) of the Mediterranean diet, seven studies ( n = 313) of the ketogenic diet and one study ( n = 37) of the MIND diet. +3 more findings

  4. 2023-01-06
  5. 2023-01-06

    FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer's Disease

    ⚠ Regulatory decision — not a study Treatments U.S. Food and Drug Administration (announced via Biogen press release)

    Key finding: Accelerated approval based on amyloid-PET reduction from Phase 2 data, not yet on proven cognitive benefit +2 more findings

  6. 2023-01-05

    Enrichment of dementia caregiving relationships through psychosocial interventions: A scoping review

    ✓ Peer-reviewed Caregiving Frontiers in medicine

    Key finding: Psychosocial interventions generating enrichment among dyads mainly involved supporting dyadic engagement in shared activities, carer education or training, or structural change to the environment around PLWD. +4 more findings

  7. 2023-01-05

    Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights

    ✓ Peer-reviewed Brain tissue and pathology Brain : a journal of neurology

    Key finding: Elaborating on the results, we validated one finding using a quantitative assessment of TDP-43 pathology in the granular layer of the hippocampus in FTLD-TDP brain donors with (n = 15) and without (n = 15) hallucinations. +2 more findings

  8. 2023-01-05

    Single-cell-led drug repurposing for Alzheimer's disease

    ✓ Peer-reviewed Drug development Scientific reports

    Key finding: Using single-cell RNA sequencing data of brain tissues from patients with Alzheimer's disease, genome-wide association study results, and multiple gene annotation resources, we built a multi-cellular Alzheimer's disease molecular network that we leveraged for gaining cell-specific insights into Alzheimer's disease pathophysiology and for the identification of drug repurposing candidates.

  9. 2023-01-05

    Lecanemab in Early Alzheimer's Disease

    ✓ Peer-reviewed Clinical trials New England Journal of Medicine

    Key finding: n=1,795 (898 lecanemab, 897 placebo); 18-month double-blind Phase 3 trial +2 more findings

  10. 2023-01-04

    Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Annals of neurology

    Key finding: We found that a higher PGS was associated with higher rates of tau-PET accumulation, in particular at elevated amyloid-PET levels. +3 more findings

  11. 2023-01-03

    Jacob-induced transcriptional inactivation of CREB promotes Aβ-induced synapse loss in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms The EMBO journal

    Key finding: Here, we report that Aβ elicits nucleocytoplasmic trafficking of Jacob, a protein that connects a NMDA-receptor-derived signalosome to CREB, in AD patient brains and mouse hippocampal neurons. +4 more findings

  12. 2023-01-03

    Age- and sex-specific modifiable risk factor profiles of dementia: evidence from the UK Biobank

    ✓ Peer-reviewed Long-term cohort studies European journal of epidemiology

    Key finding: To characterize the age- and sex-specific modifiable risk factor profiles of dementia, we included 497,401 UK Biobank participants (mean age = 56.5 years) without dementia at baseline (2006-2010) and followed them until March 2021. +3 more findings

  13. 2023-01-03

    Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries

    ✓ Peer-reviewed Treatments JAMA network open

    Key finding: This cohort study of Medicare beneficiaries suggests that use of antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors was associated with lower risk of ADRD compared with antihypertensive medications that inhibit these receptors. +4 more findings

  14. 2023-01-03

    Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline

    ✓ Peer-reviewed Biomarkers JAMA network open

    Key finding: After disclosure, 27 patients with amyloid-positive SCD+ (median [IQR] age, 70 [66-74] years; gender: 14 men [52%]; median [IQR] education: 15 [13 to 17] years, median [IQR] Mini-Mental State Examination [MMSE] score, 29 [28 to 30]) had higher median (IQR) IES-R total score (10 [2 to 14] vs 0 [0 to 2]; P Conclusions and relevance The disclosure of a positive amyloid-PET result to patients with SCD+ was associated with a bigger psychological change, yet such change did not reach the threshold for clinical concern. +4 more findings

  15. 2023-01-03

    Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers

    ✓ Peer-reviewed Biomarkers JAMA network open

    Key finding: Of 6256 participants (3402 women [54.4%]; mean [SD] age at baseline, 61.7 [6.6] years), 510 received an all-cause dementia diagnosis within 17 years of baseline. +2 more findings

  16. 2023-01-01

    DICE-Net: A Novel Convolution-Transformer Architecture for Alzheimer Detection in EEG Signals

    ✓ Peer-reviewed Digital health tools IEEE Access

    Key finding: Our results show that DICE-net achieved an accuracy of 83.28% in the AD-CN problem using Leave-One-Subject-Out validation, outperforming several baseline models, and achieving good generalization performance. +2 more findings

  17. 2023 year only

    Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life

    ✓ Peer-reviewed Costs and economics Journal of Alzheimer's disease : JAD

    Key finding: Community dwellers with dementia were more likely than those without dementia to receive life-sustaining treatments in their last 90 days of life (advanced dementia: OR = 1.83 [1.42-2.35]; non-advanced dementia: OR = 1.16 [1.01-1.32]). +4 more findings

  18. 2023 year only

    Exploring Reasons for Differential Vulnerability and Alzheimer's Disease Risk in Racial and Ethnic Minorities

    ✓ Peer-reviewed Disparities Journal of Alzheimer's disease : JAD

    Key finding: When considering race/ethnicity, the presence of more vascular comorbidities drove greater vulnerability. +3 more findings

  19. 2023 year only

    Palliative care in Parkinson disease and related disorders

    ✓ Peer-reviewed End-of-life care Handbook of clinical neurology

    Key finding: Although neuropalliative care is a relatively new field, there is increasing evidence for its use among the degenerative parkinsonian syndromes, including idiopathic Parkinson disease, progressive supranuclear palsy, multiple system atrophy, dementia with Lewy bodies, and corticobasal syndrome. +2 more findings

  20. 2023 year only

    Editorial: Social Determinants of Maintaining Nutrition in Older Adults with Advanced Dementia

    ✓ Peer-reviewed End-of-life care The journal of nutrition, health & aging

    Key finding: Dysphagia is recognised as part of the frailty syndrome, especially for those at the end of life. +2 more findings

  21. 2023 year only

    miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy

    ✓ Peer-reviewed Disease mechanisms Journal of Parkinson's disease

    Key finding: We found several deregulated biological processes linked to the synapse. miR-101a-3p was validated as a synaptic miRNA upregulated in aSyn Tg mice and in the cortex of dementia with Lewy bodies patients. +4 more findings

  22. 2023 year only

    ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS

    ✓ Peer-reviewed Disease mechanisms Arquivos de gastroenterologia

    Key finding: The composition of the gut microbiota influences the CNS, resulting in changes in host behavior and may be related to the development of neurodegenerative diseases. +3 more findings

  23. 2023 year only

    Gut-derived β-amyloid: Likely a centerpiece of the gut-brain axis contributing to Alzheimer's pathogenesis

    ✓ Peer-reviewed Disease mechanisms Gut microbes

    Key finding: To achieve this goal, the expression levels of Aβ and several key proteins involved in Aβ metabolism were initially assessed in mouse gut, with key results confirmed in human tissue. +4 more findings

  24. 2023 year only

    Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study

    ✓ Peer-reviewed Prevention and risk Journal of Alzheimer's disease : JAD

    Key finding: Most risk factors under study (i.e., hyperglycemia, unhealthy diet, lower cardiorespiratory fitness, smoking, alcohol consumption, and hypertension) were significantly associated with lower retinal sensitivity and lower RNFL thickness. +1 more finding

  25. 2023 year only

    Impact of the MIND Diet on Cognition in Individuals with Dementia

    ✓ Peer-reviewed Prevention and risk Journal of Alzheimer's disease : JAD

    Key finding: The search generated 33 papers, which yielded 11 articles after screening. +4 more findings

Browse the library by subject, with the full score breakdown →